Linda Greene
Associate
Let's Connect
Linda represents clients in a wide variety of litigation matters, including securities, patent, and complex-commercial litigation. She is also a Navy veteran and was previously a judicial extern for the Hon. John Z. Lee of the U.S. District Court for the Northern District of Illinois.
Key Matters
- Defended Becton, Dickinson and Company and certain current and former officers in a securities fraud class action in New Jersey federal district court asserting claims under Sections 10 and 20 of the Securities Exchange Act of 1934 and SEC Rule 10b-5 and alleging that material misrepresentations and omissions about the regulatory status of a key product. Additionally, Linda assisted with responding to the follow-on shareholder derivative demand.
- Defending Jernigan Capital, Inc. and its board of directors in parallel securities class actions in the Southern District of New York and Tennessee state court in connection with a take-private deal against claims brought under Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 and for breach of fiduciary duties.
- Represented Pendrell Corporation and various officers and directors in a stockholder class action filed in the Delaware Court of Chancery alleging breach of fiduciary duty and disclosure claims and challenging a US $2.1B special purpose acquisition company (SPAC) merger between Holicity, Inc. and Astra Space, Inc.
- Secured dismissal on a motion to dismiss Securities Act of 1933 claims in Indiana state court against underwriters of a secondary public offering of stock by an animal health company, and currently defending the underwriters in the pending appeal.
- Currently representing the former CEO of a publicly traded spatial data platform company in a Delaware Supreme Court appeal seeking to affirm damages awarded for the issuer’s refusal to transfer.
- Defending former CFO of an international pharmaceuticals company against multiple shareholders alleging violations of Section 10(b) in the District of New Jersey.
- Defended a drug rehabilitation center and its CEO during the investigation and resulting SEC enforcement action alleging violations of Sections 5 of Securities Act and 10(b) of the Exchange Act.
- Represented the former CFO of a public company in an SEC investigation related to alleged improprieties in the company’s financial reporting.